These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7649251)

  • 1. Influence of synthetic peptides, corresponding to fragments of the human alpha-2 interferon molecule, on the proliferation of lymphoblastoid cells in vitro. Growth inhibition and receptor binding.
    Danilkovich A; Freze K; Romashkova J; Valujskikh A; Makarov E; Targoni O; Makarova N; Kushch A
    FEBS Lett; 1995 Aug; 369(2-3):161-4. PubMed ID: 7649251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of synthetic peptide fragments of the human interferon-alpha 2.
    Danilkovitch A; Freze K; Romashkova J; Makarov E
    Hybridoma; 1997 Feb; 16(1):69-75. PubMed ID: 9085132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological properties of chimeric interferon-alpha2b peptides.
    Peña C; Blank VC; Marino VJ; Roguin LP
    Peptides; 2005 Jul; 26(7):1144-9. PubMed ID: 15949632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide with antiproliferative activity: a short C-terminal fragment of the human interferon alpha-2 molecule.
    Danilkovich AV; Freze KV; Shevalier AF; Samukov VV; Kirkin AF; Gusev MV
    Immunol Lett; 1992 Jan; 31(1):15-9. PubMed ID: 1548030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a synthetic peptide of the interferon alpha-2 C-terminal part with human blood leukocytes. Binding to peripheral blood mononuclear cells.
    Danilkovitch AV; Kharitonenkov AI; Freze KV; Shevalier AF; Kolosova OV; Bulargina TV; Kirkin AF; Gusev MV
    FEBS Lett; 1991 Dec; 295(1-3):70-2. PubMed ID: 1765172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
    Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
    J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-alpha.
    Hu R; Gan Y; Liu J; Miller D; Zoon KC
    J Biol Chem; 1993 Jun; 268(17):12591-5. PubMed ID: 8509399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of synthetic peptide corresponding to the ACTH-like sequence of human immunoglobulin G1 on proliferation of lymphoblastoid cells.
    Lepikhova TN; Navolotskaya EV; Zargarova TA; Nurieva RI; Lipkin VM; Zav'yalov VP
    Peptides; 2000 Mar; 21(3):353-7. PubMed ID: 10793216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological effects of synthetic peptide, a fragment of C-terminal region of human interferon-2alpha, in a Daudi cell line].
    Romashkova IaA; Danilkovich AV; Valuĭskikh AN; Pershina VV; Freze KV; Sukhikh GT
    Biull Eksp Biol Med; 1997 Apr; 123(4):446-8. PubMed ID: 9190191
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon receptor recognition peptides enhance the biological potency of interferon alphas.
    Fish EN
    FEBS Lett; 1995 May; 365(1):87-91. PubMed ID: 7774722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical and biological properties of synthetic peptide fragments from the 124-144 sequence of human leukocyte interferon alpha2].
    Sheval'e AF; Samukov VV; Ofitserov VI; Kalashnikov VV; Mizenko GA; Kolokol'tsov AA
    Bioorg Khim; 1990 Jul; 16(7):916-25. PubMed ID: 1700715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early lymphocyte activation events are inhibited by antiproliferative synthetic peptide 2438, a fragment of human interferon alpha-2, and immunosuppressant cyclosporine A.
    Freze KV; Danilkovich AV; Kharitonenkov AI; Shevalier AF; Surin AM; Khodorova AB; Astashkin EI; Bulargina TV
    Biochem Mol Biol Int; 1994 Aug; 33(5):969-79. PubMed ID: 7527265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminus of IFN gamma is sufficient for intracellular function.
    Szente BE; Soos JM; Johnson HW
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1645-54. PubMed ID: 7945313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding site on the murine IFN-gamma receptor for IFN-gamma has been identified using the synthetic peptide approach.
    VanVolkenburg MA; Griggs ND; Jarpe MA; Pace JL; Russell SW; Johnson HM
    J Immunol; 1993 Dec; 151(11):6206-13. PubMed ID: 8245462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of interleukin-2-dependent proliferation of human lymphocytes and expression of interleukin-2 receptors by synthetic peptides--fragments of alpha-2 interferon].
    Danilkovich AV; Freze KV; Targoni OS; Karulin AIu; Sheval'e AF; Gusev MV; Sukhikh GT
    Biull Eksp Biol Med; 1994 Jan; 117(1):65-8. PubMed ID: 8193336
    [No Abstract]   [Full Text] [Related]  

  • 18. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
    Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
    J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma.
    Magazine HI; Johnson HM
    Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.